1. Corrigendum to "The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management" [Thromb. Res., 194, October 2020, Pages 101–115]. Issue 204 (August 2021) Authors: Abou-Ismail, Mouhamed Yazan; Diamond, Akiva; Kapoor, Sargam; Arafah, Yasmin; Nayak, Lalitha Journal: Thrombosis research Issue: Issue 204(2021) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B‐cell lymphoma and treated with anthracyclines. Issue 4 (4th June 2022) Authors: Diamond, Akiva; Ayyappan, Sabarish; Cao, Shufen; Tashtish, Nour; Boughan, Kirsten; Cooper, Brenda; Fu, PingFu; Caimi, Paolo F. Journal: Hematological oncology Issue: Volume 40:Issue 4(2022) Page Start: 626 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Issue 194 (October 2020) Authors: Abou-Ismail, Mouhamed Yazan; Diamond, Akiva; Kapoor, Sargam; Arafah, Yasmin; Nayak, Lalitha Journal: Thrombosis research Issue: Issue 194(2020) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗